Related Experiment Video
Updated: Oct 23, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Characterizing Multimorbidity from Type 2 Diabetes: Insights from Clustering Approaches
Meryem Cicek1, James Buckley2, Jonathan Pearson-Stuttard2
1Department of Primary Care and Public Health, School of Public Health, Imperial College London, Charing Cross Campus, Reynolds Building, St Dunstan's Road, London W6 8RP, UK.
Patients with type 2 diabetes mellitus (T2DM) often develop multimorbidity, with three main clusters: cardiometabolic, vascular, and mental health conditions. Early detection and holistic care are recommended for better patient outcomes.
Area of Science:
- Endocrinology and Metabolism
- Public Health
- Clinical Medicine
Background:
- Type 2 diabetes mellitus (T2DM) is frequently associated with multimorbidity, impacting patient care and quality of life.
- Limited literature exists on characterizing T2DM-related multimorbidity patterns.
- Understanding these patterns is crucial for effective patient management.
Purpose of the Study:
- To review and summarize emerging literature on T2DM-related multimorbidity clusters.
- To characterize and quantify the associations between T2DM and co-occurring conditions.
- To identify dominant patterns of multimorbidity in T2DM patients.
Main Methods:
- Systematic review of existing literature.
- Analysis of studies characterizing T2DM-associated multimorbidity.
- Identification and categorization of common multimorbidity clusters.
Main Results:
- Three dominant clusters of multimorbidity were identified in patients with T2DM.
- These clusters include cardiometabolic precursor conditions, vascular conditions, and mental health conditions.
- The findings highlight specific co-occurrence patterns in T2DM patients.
Conclusions:
- Holistic patient care for T2DM should incorporate early detection of comorbidities.
- Consideration of a wider range of risk factors beyond glycemic control is essential.
- Addressing identified multimorbidity clusters can improve clinical care and patient outcomes.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

